PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25465546-7	2015	injections of 4mg of quinagolide, a specific inhibitor of PRL release, from 5 d before drying-off until 13 d after (QN).	quinagolide	21-32	prolactin	Bos taurus	58-61	
31280741-2	2019	Accordingly, the inhibition of PRL secretion by the dopamine agonists quinagolide and cabergoline causes a sharp decline in milk production and could be useful in several critical periods.	quinagolide	70-81	prolactin	Bos taurus	31-34	
26547648-5	2016	Quinagolide reduced milking-induced PRL release and caused a faster decline in milk production.	quinagolide	0-11	prolactin	Bos taurus	36-39	
26547648-15	2016	In addition, quinagolide improved the resistance to intramammary infection, suggesting that PRL inhibition could be an alternative strategy for facilitating drying-off.	quinagolide	13-24	prolactin	Bos taurus	92-95	
26387019-1	2015	It has been previously shown that the long-term inhibition of milking-induced prolactin (PRL) release by quinagolide (QN), a dopamine agonist, reduces milk yield in dairy cows.	quinagolide	105-116	prolactin	Bos taurus	78-87	
26387019-1	2015	It has been previously shown that the long-term inhibition of milking-induced prolactin (PRL) release by quinagolide (QN), a dopamine agonist, reduces milk yield in dairy cows.	quinagolide	105-116	prolactin	Bos taurus	89-92	
26387019-1	2015	It has been previously shown that the long-term inhibition of milking-induced prolactin (PRL) release by quinagolide (QN), a dopamine agonist, reduces milk yield in dairy cows.	quinagolide	118-120	prolactin	Bos taurus	78-87	
26387019-1	2015	It has been previously shown that the long-term inhibition of milking-induced prolactin (PRL) release by quinagolide (QN), a dopamine agonist, reduces milk yield in dairy cows.	quinagolide	118-120	prolactin	Bos taurus	89-92	
26298751-1	2015	In previous studies, our team showed that the inhibition of prolactin (PRL) secretion by the dopamine agonist quinagolide reduces milk production in dairy cows.	quinagolide	110-121	prolactin	Bos taurus	60-69	
26298751-1	2015	In previous studies, our team showed that the inhibition of prolactin (PRL) secretion by the dopamine agonist quinagolide reduces milk production in dairy cows.	quinagolide	110-121	prolactin	Bos taurus	71-74	
25465546-9	2015	Quinagolide induced a decrease in PRL concentration in blood on all the injection days.	quinagolide	0-11	prolactin	Bos taurus	34-37	
24881791-7	2014	injections of 4mg of quinagolide, a specific inhibitor of PRL release, from 5d before drying off until 13d after (QN; n=8).	quinagolide	21-32	prolactin	Bos taurus	58-61	
24881791-8	2014	Quinagolide induced a decrease in PRL concentration in blood and in milk and mammary secretions on all the injection days.	quinagolide	0-11	prolactin	Bos taurus	34-37	
22281117-5	2012	In a first experiment, daily injections of the PRL inhibitor quinagolide reduced milking-induced PRL release and induced a faster decline in milk production.	quinagolide	61-72	prolactin	Bos taurus	47-50	
23164222-6	2013	Of those cows, 8 received twice-daily intramuscular injections (2 mg per injection) of quinagolide, a specific inhibitor of PRL release, from 4 d before drying-off to 3 d after (Quin).	quinagolide	87-98	prolactin	Bos taurus	124-127	
23164222-10	2013	Quinagolide reduced basal serum PRL concentrations on all injection days as well as PRL released in blood during milking.	quinagolide	0-11	prolactin	Bos taurus	32-35	
22281117-5	2012	In a first experiment, daily injections of the PRL inhibitor quinagolide reduced milking-induced PRL release and induced a faster decline in milk production.	quinagolide	61-72	prolactin	Bos taurus	97-100	
22281117-9	2012	The inhibition of milk production by quinagolide was maintained in the udder half that was milked 2x but not in the udder half milked 1x, suggesting that the response to PRL is modulated at the gland level.	quinagolide	37-48	prolactin	Bos taurus	170-173	
22192196-0	2012	Mammary cell activity and turnover in dairy cows treated with the prolactin-release inhibitor quinagolide and milked once daily.	quinagolide	94-105	prolactin	Bos taurus	66-75	
22192196-2	2012	injections of 1mg of quinagolide, a suppressor of PRL release, for 9 wk, whereas 4 control cows received the vehicle (water) only.	quinagolide	21-32	prolactin	Bos taurus	50-53	
22192196-12	2012	In conclusion, the reduction in milk yield after chronic administration of the PRL-release inhibitor quinagolide is associated with a reduction in mammary cell activity, survival, and proliferation in lactating dairy cows.	quinagolide	101-112	prolactin	Bos taurus	79-82	
21338795-2	2011	To assess the effect of the long-term inhibition of PRL release in lactating dairy cows, 5 Holstein cows in early lactation received daily intramuscular injections of 1mg of the PRL-release inhibitor quinagolide for 9 wk.	quinagolide	200-211	prolactin	Bos taurus	178-181	
21338795-6	2011	The daily injections of quinagolide reduced milking-induced PRL release but not the basal PRL concentration.	quinagolide	24-35	prolactin	Bos taurus	60-63	
21338795-13	2011	In conclusion, the chronic administration of the PRL-release inhibitor quinagolide decreases milk production in dairy cows.	quinagolide	71-82	prolactin	Bos taurus	49-52